COVID-19:’Delta mutant’spread in China: Guangzhou, Shenzhen, Senshan, Dongguan
Keio University: iPS cells treat corneal diseases: vesicular keratopathy
Tohoku University: Therapeutic effect on cerebral infarction: Muse cell preparation “CL2020”
Kyoto University: Providing iPS cells to Novo Nordisk: Macrophage research
FUJIFILM: Treatment of eye diseases with iPS: Technology licensed to BlueRock